WealthCare Investment Partners’s Amgen AMGN Stock Holding History

WealthCare Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Buy	783 +6	+0.8%	+$2.05K	0.07%	167
2026 Q1	$275K	Sell	777 -5	-0.6%	-$1.78K	0.08%	161
2025 Q4	$256K	Sell	782 -10	-1%	-$3.17K	0.07%	161
2025 Q3	$236K	Buy	792 +7	+0.9%	+$2.03K	0.08%	157
2025 Q2	$234K	Buy	785 +6	+0.8%	+$1.7K	0.08%	143
2025 Q1	$213K	Hold	779	–	–	0.09%	140
2024 Q4	$202K	Buy	779 +6	+0.8%	+$1.78K	0.09%	143
2024 Q3	$245K	Sell	773 -143	-16%	-$46.8K	0.11%	123
2024 Q2	$286K	Buy	+916	New	+$269K	0.13%	109

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WealthCare Investment Partners's AMGN Position: Q2 2026 in Review

WealthCare Investment Partners increased its Amgen (AMGN) stake by 0.77% in Q2 2026, buying an estimated $2.05K and bringing the position to 783 shares worth $283K. The position accounts for 0.07% of the portfolio, ranked #167.

WealthCare Investment Partners first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $286K in Q2 2024. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

WealthCare Investment Partners held 783 shares of Amgen worth $283K as of Q2 2026.
WealthCare Investment Partners bought 6 Amgen shares in Q2 2026, an estimated $2.05K.
Amgen made up 0.07% of WealthCare Investment Partners's portfolio in Q2 2026, its #167 holding.
WealthCare Investment Partners first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
WealthCare Investment Partners's Amgen position peaked at $286K in Q2 2024.
3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on WealthCare Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.